Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Vascular Function in Hypertension
NCT00181181Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- May 2003
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Atorvastatin with Placebo (2 arms). Primary endpoints: Vascular Function (Brachial Artery Reactivity, Pulse Wave Velocity, Coronary Artery Flow Velocity Reserve) at 3 months, Markers of Inflammation at 3 months and 2 more. Started May 2003; status: terminated.
02
Drugs
atorvastatin
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00181181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181181.